Novogen Ltd. (Nasdaq: NVGN) reported that its Anisina demonstrated potential to destroy a cancer cell's cytoskeleton. The stock price leaped 80 cents to close at $3.88.
Novogen's Anisina show potential against cancer
March 18, 2015 at 18:57 PM EDT
